Learn more →
Back to Expert Scholars
clinical / clinicalgastric cancer Korea molecular subtypes

Keun-Wook Lee

李根旭

MD, PhD

🏢Seoul National University Bundang Hospital(首尔国立大学盆唐医院)🌐South Korea

Professor of Medical Oncology内科肿瘤学教授

48
h-index
2
Key Papers
2
Awards
2
Key Contributions

👥Biography 个人简介

Keun-Wook Lee is a Korean gastric cancer oncologist who has contributed to Korean Cancer Study Group (KCSG) clinical trials and translational research on molecular subtypes of gastric cancer. He has contributed to evaluation of ramucirumab in Asian gastric cancer populations and has investigated EBV-positive and MSI-H gastric cancer as distinct molecular subtypes with different immunotherapy sensitivities. Lee leads molecular tumor board integration at Seoul National University Bundang Hospital and has contributed to Korean National Cancer Center gastric cancer guidelines. His research spans HER2 testing standards, CLDN18.2 selection methods, and biomarker harmonization for gastric cancer in Korea.

Share:

🧪Research Fields 研究领域

gastric cancer EBV胃癌EBV
MSI gastric cancerMSI胃癌
Korean gastric cancer trials韩国胃癌试验
VEGFR2 gastric cancerVEGFR2胃癌
ramucirumab gastric雷莫芦单抗胃癌

🎓Key Contributions 主要贡献

Molecular Subtype-Based Gastric Cancer Treatment

Advanced clinical application of TCGA-based molecular classification in Korean gastric cancer cohorts, demonstrating differential immunotherapy response based on EBV, MSI-H, and CIN subtypes in Asian patients.

KCSG Gastric Cancer Trial Leadership

Led Korean Cancer Study Group gastric cancer trials evaluating novel combinations and biomarker-selected populations, generating Korean-specific evidence to complement Western trial data.

Representative Works 代表性著作

[1]

EBV-Positive Gastric Cancer and Immune Response to Checkpoint Inhibitors

Clinical Cancer Research (2019)

EBV gastric cancer molecular biology and immunotherapy sensitivity.

[2]

Ramucirumab plus Paclitaxel versus Placebo plus Paclitaxel in Patients with Previously Treated Advanced Gastric Cancer (RAINBOW)

Lancet Oncology (2014)

RAINBOW trial Korean patient subset contributing to ramucirumab approval.

🏆Awards & Recognition 奖项与荣誉

🏆Korean Cancer Association Research Award
🏆KCSG Scientific Excellence Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 李根旭 的研究动态

Follow Keun-Wook Lee's research updates

留下邮箱,当我们发布与 Keun-Wook Lee(Seoul National University Bundang Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment